11.11.2009 • News

Bayer Cropscience Buys U.S. Biotech Company Athenix

Bayer Cropscience announced that it has entered into an agreement to purchase Athenix, a privately-held independent biotechnology company. The acquisition of Athenix and its innovative technology platform will boost Bayer Cropscience's ability to make available novel technology and complete agricultural solutions to growers worldwide. The acquisition is subject to premerger notification. The final purchase price is yet to be disclosed.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read